CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 114 filers reported holding CULLINAN ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $100,291,912 | +84.1% | 5,750,683 | +79.9% | 2.81% | +87.7% |
| Q1 2024 | $54,471,785 | +67.2% | 3,196,701 | 0.0% | 1.50% | +83.8% |
| Q4 2023 | $32,574,383 | +12.6% | 3,196,701 | 0.0% | 0.82% | +4.5% |
| Q3 2023 | $28,930,144 | -15.9% | 3,196,701 | 0.0% | 0.78% | -18.7% |
| Q2 2023 | $34,396,503 | +5.2% | 3,196,701 | 0.0% | 0.96% | -19.7% |
| Q1 2023 | $32,702,251 | -58.7% | 3,196,701 | -57.4% | 1.20% | -64.3% |
| Q4 2022 | $79,220,572 | -17.7% | 7,509,059 | 0.0% | 3.34% | -15.9% |
| Q3 2022 | $96,266,000 | 0.0% | 7,509,059 | 0.0% | 3.98% | -14.5% |
| Q2 2022 | $96,266,000 | +71.2% | 7,509,059 | +39.8% | 4.65% | +106.7% |
| Q1 2022 | $56,218,000 | -32.1% | 5,369,459 | 0.0% | 2.25% | -25.2% |
| Q4 2021 | $82,851,000 | +399.4% | 5,369,459 | +630.4% | 3.01% | +364.8% |
| Q3 2021 | $16,591,000 | -12.4% | 735,106 | 0.0% | 0.65% | -8.7% |
| Q2 2021 | $18,929,000 | -56.7% | 735,106 | -29.9% | 0.71% | -56.7% |
| Q1 2021 | $43,727,000 | – | 1,049,356 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |